Newsletter
Industry Watch
In this third week of January, we bring our readers research updates on antibiotic resistance, and how in comparison, resistance to vaccines is rare.…
All Results
Newsletter
Blog
COVID-19 Fuels Innovation and Advancements in Healthcare Technology
The COVID-19 pandemic has forced the healthcare technology industry to dial-up innovation at an unprecedented pace. Healthcare professionals have…
Blog
Ask the Experts Roundtable: Insights on Pfizer and Moderna’s Recent mRNA-Based Vaccine Developments
As the COVID-19 pandemic continues to challenge humankind worldwide, the medical industry and professionals alike are developing vaccines at…
Blog
CRISPR Technology Offers New Hope for Patients with Devastating Diseases
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) is a powerful new gene-editing tool with unprecedented implications for the future…
Newsletter
Industry Watch
As we move into the final quarter of 2020, we bring you news of the discovery of a rare genetic form of dementia known as Vacuolar Tauopathy. From…
Publication
Successful Adaptation to the Evolution of Complex Dose Escalation Within a Large Master Protocol Basket Design Across IO Co-Therapies
A case study describing a Phase I dose escalation and cohort expansion study of an immune checkpoint inhibitor in patients with advanced solid…
Blog
Receiving Your Seasonal Flu Vaccine is Important to the Management of COVID-19
This influenza season, we will face two infectious diseases. The northern hemisphere is now entering the influenza (flu) season. Without a COVID-19…
Newsletter
Industry Watch
In the second week of August, we bring you news of an existing arthritis drug could help a third of diabetes patients, delaying the progress of the…
Newsletter
Industry Watch
In the second week of July, we bring you news of developments in HIV research, as well as updates on immunotherapies, Alzheimer’s disease,…
Page
The Center for Immuno-oncology, Cellular, and Gene Therapy
We provide end-to-end support for your complex, fast-paced immunotherapy studies.